One lozenge,
one press.
LOZZIN is developing a nicotine polacrilex lozenge — a stop smoking aid in mint and citrus, 2 mg and 4 mg, in a button-release case that dispenses a single lozenge at a time.
We're in formulation and regulatory work now. Leave your email and we'll tell you when it's real — nothing else.
Launch and wholesale updates only. No marketing lists, no resale of your address.
WARNING: This product contains nicotine.
Nicotine is an addictive chemical.
Keep out of reach of children and pets.
The lozenge
A pressed oval, smooth-faced and lightly domed, sized to sit against the cheek without being fussed with. The shape is the mark — the O in LOZ is the product, drawn to scale.
Nicotine polacrilex
The nicotine ion-exchange resin complex used in established OTC lozenges, at the standard 2 mg and 4 mg strengths.
Two flavors
Mint and citrus, each offered in both strengths — four SKUs total, sized for a single c-store facing.
Buccal, not chewed
Parked against the cheek and allowed to dissolve. Not chewed, not swallowed whole.
Product lines
Two flavors, two strengths, four SKUs. Strength selection follows the standard NRT rule — 4 mg for a first cigarette within 30 minutes of waking, 2 mg for later than that.
Cool and clean. The default for most people stepping down.
Same flavor, higher strength for heavier morning smokers.
Brighter and less medicinal for people who don't want mint.
The higher strength in the non-mint line.
The case
A disposable polypropylene case proportioned to the golden ratio — 58 mm by 94 mm, a 1 : 1.618 rectangle. Press the button and one lozenge comes out. Nothing else does.
Single-dose button
A top-edge press releases exactly one lozenge. No tipping the container into your palm and no touching the rest of the dose.
Child lock on the edge
A slide lock on the left edge the button won't fire without. Targeted to child-resistant performance under 16 CFR 1700.
Dose you can see
A clear chamber shows the lozenges themselves, at true size. You know what's left without opening anything.
Specifications
Targets, not final. Everything here is subject to formulation, stability testing, child-resistance testing, and FDA review.
- Active ingredient
- Nicotine polacrilex
- Strengths
- 2 mg and 4 mg per lozenge
- Flavors
- Mint, Citrus
- SKUs
- Four — Mint 2 mg, Mint 4 mg, Citrus 2 mg, Citrus 4 mg
- Count per case
- 27 lozenges
- Indication
- Stop smoking aid (reduces withdrawal symptoms, including nicotine craving)
- Route
- Oral, buccal absorption — not chewed or swallowed whole
- Lozenge form
- Pressed oval, lightly domed faces
- Case dimensions
- 58 mm × 94 mm (1 : 1.618), 16 mm deep
- Case material
- Polypropylene (resin code 5), single-use disposable
- Dispensing
- Press-button single-lozenge release
- Child resistance
- Edge slide lock, target per 16 CFR 1700
- Regulatory class
- OTC drug product, FDA Center for Drug Evaluation and Research
- Labeling
- Drug Facts panel per 21 CFR 201.66
- Status
- Pre-launch. No FDA-authorized product yet; not offered for sale.
Distributors & retail
If you buy for a convenience chain, a wholesaler, or a distribution group, we'd like to talk early — while case configuration and planogram sizing are still open.
Important safety information
This product is not currently available for sale. LOZZIN has no FDA-approved product on the market. Nothing on this page is an offer to sell, and no claim here has been evaluated for a finished LOZZIN product.
Nicotine replacement lozenges are stop smoking aids intended for adults. If you are pregnant or breastfeeding, using any other nicotine-containing product, or under a doctor's care for heart disease, recent heart attack, irregular heartbeat, or high blood pressure, talk to your doctor before using nicotine replacement products.
Nicotine is toxic in small amounts, and a child-resistant case is not childproof. Keep lozenges, cases, and used lozenges out of reach of children and pets. In case of overdose, get medical help or contact a Poison Control Center at 1-800-222-1222 right away.